Chronic Antibody-mediated Rejection (cABMR)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Chronic Antibody-mediated Rejection (cABMR) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT06886646

Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney T…

Kidney transplantation is the best treatment for end-stage chronic kidney disease (CKD), improving survival and quality of life, while reducing treatment costs.…

France22 participantsStarted 2025-09-15

Treatment: Allogeneic Mesenchymal Stromal Cell Therapy, Placebo (NaCl 0.9%) Treatment